WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
33.82
+0.22 (+0.65%)
At close: 3:49PM EDT
Stock chart is not supported by your current browser
Previous Close 33.60
Open 33.49
Bid 33.76 x 0
Ask 33.84 x 0
Day's Range 33.20 - 34.56
52 Week Range 30.30 - 76.68
Volume 985,684
Avg. Volume 1,843,425
Market Cap 11.765B
Beta (3Y Monthly) 5.40
PE Ratio (TTM) N/A
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
All
News
Press Releases
  • PR Newswire

    Canopy Growth Announces Election of Board of Directors

    SMITHS FALLS, ON , Sept. 17, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX:WEED) (NYSE: CGC) ("Canopy Growth" or "the Corporation") today announced that all of management's nominees ...

  • CNW Group

    /R E P E A T -- Alan Cooke Joins EuroLife as Strategic Advisor Following Success at Canopy Growth/

    /R E P E A T -- Alan Cooke Joins EuroLife as Strategic Advisor Following Success at Canopy Growth/

  • Wolverine Partners Corp. to Change Name to Gage Growth Corp. and Appoint Bruce Linton as Executive Chairman
    CNW Group

    Wolverine Partners Corp. to Change Name to Gage Growth Corp. and Appoint Bruce Linton as Executive Chairman

    Gage Cannabis Co.) (the "Company" or "Gage"), one of Michigan's leading craft cannabis and brand platforms, today announced the proposed change of its corporate name to Gage Growth Corp. and addition of Bruce Linton , who will be appointed to the role of Executive Chairman. The changes are expected to be made effective in connection with the closing of Gage's proposed acquisition of Rivers Innovations Inc. ("Innovations").

  • CNW Group

    /R E P E A T -- Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals/

    MONTREAL and SMITHS FALLS, ON , Sept. 16, 2019 /CNW/ - Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Santé Cannabis, a pioneer in medical cannabis in Québec, has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (WEED.TO) (CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

  • CNW Group

    Alan Cooke Joins EuroLife as Strategic Advisor Following Success at Canopy Growth

    Alan Cooke Joins EuroLife as Strategic Advisor Following Success at Canopy Growth

  • CNW Group

    Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals

    MONTREAL and SMITHS FALLS, ON , Sept. 16, 2019 /CNW/ - Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Santé Cannabis, a pioneer in medical cannabis in Québec, has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (WEED.TO) (CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

  • PR Newswire

    Canopy Rivers Launches Strategic Advisory Board

    TORONTO, Sept. 11, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies. "We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages
    CNW Group

    Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages

    Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages

  • Canopy Growth Receives Key Extraction Licence
    PR Newswire

    Canopy Growth Receives Key Extraction Licence

    SMITHS FALLS, ON, Aug. 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED), (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has received a licence from Health Canada for its KeyLeaf Life Sciences ("KeyLeaf") facility in Saskatoon, Saskatchewan. Including the Smiths Falls site and the recently licensed BC Tweed extraction site, Canopy Growth now operates three significant extraction assets to support the throughput required for large scale value-add product development. Canopy Growth recently retrofitted the now fully licensed KeyLeaf facility in Saskatchewan, a company with over 50 years of experience in the extraction industry.

  • CNW Group

    /R E P E A T -- From Revolution to Evolution: Cannabis Culture 50 years later/

    Now, 50 years later, the crowd that started it all has become one of the most important, influential and educated consumer groups in the legal cannabis market—the 55+ Boomers. "Over the past two months, Tweed has worked with market research firm, Leger, polling the Boomer generation for their opinions on cannabis pre and post-legalization in regards to education, community and the future of the consumer landscape," says Rade Kovacevic, President of Canopy Growth Corporation. "This is a demographic with an incredibly unique viewpoint that has experienced and observed the cannabis industry's transition from prohibition to legalization over the past 50 years.

  • /R E P E A T -- Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees/
    CNW Group

    /R E P E A T -- Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees/

    /R E P E A T -- Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees/

  • Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies
    CNW Group

    Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies

    TORONTO , Aug.15, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio companies, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF) and TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), have entered into a purchase and supply agreement, demonstrating the type of collaboration and synergy seen throughout the Canopy Rivers ecosystem. As part of the agreement, JWC will supply cannabis flower and oils to TerrAscend, which will be made available for purchase on TerrAscend's online medical sales platform, Solace Health, providing JWC with exposure to thousands of registered medical patients across Canada .

  • CNW Group

    From Revolution to Evolution: Cannabis Culture 50 years later

    Now, 50 years later, the crowd that started it all has become one of the most important, influential and educated consumer groups in the legal cannabis market—the 55+ Boomers. "Over the past two months, Tweed has worked with market research firm, Leger, polling the Boomer generation for their opinions on cannabis pre and post-legalization in regards to education, community and the future of the consumer landscape," says Rade Kovacevic, President of Canopy Growth Corporation. "This is a demographic with an incredibly unique viewpoint that has experienced and observed the cannabis industry's transition from prohibition to legalization over the past 50 years.

  • Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees
    CNW Group

    Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees

    Media Advisory - Canopy Growth to donate $100,000 to Forest Ontario to help plant millions of trees

  • CNW Group

    Canopy Growth drives revenue with 94% increase in recreational dried cannabis sales in first quarter of fiscal 2020

    Canopy Growth drives revenue with 94% increase in recreational dried cannabis sales in first quarter of fiscal 2020

  • PR Newswire

    Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO, Aug. 13, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) will report its first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. The Company's unaudited condensed interim financial statements and Management's Discussion and Analysis for the three months ended June 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investors/financials-and-public-filings. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (WEED.TO) (CGC), which are currently scheduled to be released on August 14, 2019.

  • Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics
    PR Newswire

    Canopy Growth Strengthens Position as Global Cannabis Research Leader by Entering Agreement to Acquire Beckley Canopy Therapeutics

    SMITHS FALLS, ON, Aug. 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO), (CGC) is pleased to announce that it has entered into an agreement to acquire the global cannabinoid-based medical researcher Beckley Canopy Therapeutics ("Beckley Canopy"). The acquisition brings together Canopy's wholly owned research program with the Beckley Canopy research platform which is partly owned by Canopy Growth in order to combine the best teams, programs and clinical work all under a single strategic plan. The research arm in turn directly supports the commercial efforts of Spectrum Therapeutics around the world.